Healthcare covers 35 names in the current scan, worth roughly $5.14T combined. The sector is under modest pressure, averaging -0.04% on the session.
Breadth reads 14 advancing against 20 declining — a defensive tape, with sellers in control of more names than buyers. Average RSI sits near 52, a neutral momentum backdrop.
Leadership belongs to TMO (Thermo Fisher Scientific Inc), up +1.2% on a C-grade setup. On the other side, HCA lags at -0.8%, the clearest drag on the group.
| Ticker | Name | Mkt Cap | % Chg | RSI | Grade |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $985.4B | -0.48% | 75 | — |
| JNJ | Johnson & Johnson | $542.4B | -0.30% | 53 | — |
| ABBV | AbbVie Inc. | $384.7B | +0.15% | 67 | — |
| UNH | UnitedHealth Group Incorporated | $345.4B | -0.29% | 52 | — |
| MRK | Merck & Company, Inc. | $293.2B | -0.51% | 61 | C |
| TMO | Thermo Fisher Scientific Inc | $183.0B | +1.16% | 71 | C |
| AMGN | Amgen Inc. | $181.8B | +0.06% | 51 | — |
| GILD | Gilead Sciences, Inc. | $166.9B | -0.17% | 57 | B |
| ISRG | Intuitive Surgical, Inc. | $150.4B | +0.11% | 40 | C |
| PFE | Pfizer, Inc. | $149.2B | -0.38% | 55 | C |
| ABT | Abbott Laboratories | $149.1B | +0.12% | 44 | — |
| DHR | Danaher Corporation | $129.3B | +0.33% | 70 | C |
| SYK | Stryker Corporation | $117.0B | -0.11% | 46 | C |
| BMY | Bristol-Myers Squibb Company | $116.8B | +0.51% | 42 | C |
| CVS | CVS Health Corporation | $116.1B | +0.10% | 56 | — |
| VRTX | Vertex Pharmaceuticals Incorpor | $113.6B | +0.20% | 59 | — |
| MDT | Medtronic plc. | $94.8B | -0.01% | 36 | — |
| MCK | McKesson Corporation | $89.2B | +0.01% | 46 | — |
| ELV | Elevance Health, Inc. | $85.4B | -0.14% | 52 | — |
| HCA | HCA Healthcare, Inc. | $84.0B | -0.83% | 22 | — |
| CI | The Cigna Group | $73.4B | +0.00% | 52 | — |
| BSX | Boston Scientific Corporation | $71.8B | -0.18% | 26 | C |
| REGN | Regeneron Pharmaceuticals, Inc. | $64.5B | -0.14% | 28 | — |
| COR | Cencora, Inc. | $52.4B | -0.21% | 44 | — |
| EW | Edwards Lifesciences Corporatio | $49.8B | +0.13% | 67 | B |
| CAH | Cardinal Health, Inc. | $46.1B | -0.32% | 50 | — |
| IDXX | IDEXX Laboratories, Inc. | $44.5B | +0.44% | 60 | — |
| BDX | Becton, Dickinson and Company | $40.5B | +0.58% | 49 | C |
| ALNY | Alnylam Pharmaceuticals, Inc. | $40.3B | -0.06% | 58 | C |
| HUM | Humana Inc. | $36.7B | -0.16% | 69 | C |
| ZTS | Zoetis Inc. | $32.6B | -0.59% | 34 | — |
| DXCM | DexCom, Inc. | $28.5B | +0.67% | 68 | C |
| VEEV | Veeva Systems Inc. | $28.5B | -0.30% | 56 | — |
| GEHC | GE HealthCare Technologies Inc. | $28.4B | -0.38% | 47 | — |
| INSM | Insmed Incorporated | $23.2B | -0.41% | 44 | — |
Sector membership and market caps come from cached metadata; momentum from the latest universe scan. Not investment advice — always do your own due diligence.